Publications
Selected publications
- Circulating Proteome for Pulmonary Nodule Malignancy. (Journal article - 2023)
- Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis (Journal article - 2021)
- Liverpool Lung Project lung cancer risk stratification model: calibration and prospective validation (Journal article - 2021)
- Plasma protein biomarkers for early prediction of lung cancer (Journal article - 2023)
- Unique volatolomic signatures of TP53 and KRAS in lung cells (Journal article - 2014)
- A microRNA-based prediction algorithm for diagnosis of non-small lung cell carcinoma in minimal biopsy material (Journal article - 2013)
- Heterogeneity of PD-L1 expression in non-small cell lung cancer: Implications for specimen sampling in predicting treatment response (Journal article - 2019)
- Expression and splicing of the unfolded protein response gene XBP-1 are sieniticantly associated with clinical outcome of endocrine-treated breast cancer (Journal article - 2008)
- Association of oestrogen receptor beta 2 (ERβ2/ERβcx) with outcome of adjuvant endocrine treatment for primary breast cancer -: a retrospective study (Journal article - 2007)
- Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours (Journal article - 1996)
2024
Retrospective evaluation of plasma protein tumour markers for early lung cancer detection
Davies, M. P. A., Kolamunnage-Dona, R., Phillips, S., Lambert, A., Tate, S., & Field, J. K. (2024). Retrospective evaluation of plasma protein tumour markers for early lung cancer detection. BJC Reports, 2(1). doi:10.1038/s44276-024-00082-6
On the informative value of community-based indoor radon values in relation to lung cancer.
Rosenberger, A., Bickeböller, H., Christiani, D. C., Liu, G., Schabath, M. B., Duarte, L. F., . . . Hung, R. J. (2024). On the informative value of community-based indoor radon values in relation to lung cancer.. Cancer medicine, 13(16), e70126. doi:10.1002/cam4.70126
Impact of single round of low dose CT lung cancer screening on cause of mortality in different socio-economic groups: a post-hoc analysis of long-term follow-up of the UKLS trial.
Davies, M. P. A., Vulkan, D., Gabe, R., Duffy, S. W., & Field, J. K. (2024). Impact of single round of low dose CT lung cancer screening on cause of mortality in different socio-economic groups: a post-hoc analysis of long-term follow-up of the UKLS trial.. The Lancet regional health. Europe, 42, 100936. doi:10.1016/j.lanepe.2024.100936
Novel Transcriptional and DNA Methylation Abnormalities of SORT1 Gene in Non-Small Cell Lung Cancer.
Acha-Sagredo, A., Wilson, C. M., Garcia Bediaga, N., Kalirai, H., Davies, M. P. A., Coupland, S. E., . . . Liloglou, T. (2024). Novel Transcriptional and DNA Methylation Abnormalities of SORT1 Gene in Non-Small Cell Lung Cancer.. Cancers, 16(11), 2154. doi:10.3390/cancers16112154
Lung cancer in ever- and never-smokers: findings from multi-population GWAS studies.
Li, Y., Xiao, X., Li, J., Han, Y., Cheng, C., Fernandes, G. F., . . . Amos, C. I. (2024). Lung cancer in ever- and never-smokers: findings from multi-population GWAS studies.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. doi:10.1158/1055-9965.epi-23-0613
2023
Identification of genetically predicted DNA methylation markers associated with non-small cell lung cancer risk among 34,964 cases and 448,579 controls.
Zhao, X., Yang, M., Fan, J., Wang, M., Wang, Y., Qin, N., . . . Dai, J. (2023). Identification of genetically predicted DNA methylation markers associated with non-small cell lung cancer risk among 34,964 cases and 448,579 controls.. Cancer. doi:10.1002/cncr.35130
Large-scale whole exome sequencing studies identify two genes,CTSL and APOE, associated with lung cancer.
Xu, J., Xu, W., Choi, J., Brhane, Y., Christiani, D. C., Kothari, J., . . . Briollais, L. (2023). Large-scale whole exome sequencing studies identify two genes,CTSL and APOE, associated with lung cancer.. PLoS genetics, 19(9), e1010902. doi:10.1371/journal.pgen.1010902
Association between duration of smoking abstinence before non-small-cell lung cancer diagnosis and survival: a retrospective, pooled analysis of cohort studies
Fares, A. F., Li, Y., Jiang, M., Brown, M. C., Lam, A. C. L., Aggarwal, R., . . . Liu, G. (2023). Association between duration of smoking abstinence before non-small-cell lung cancer diagnosis and survival: a retrospective, pooled analysis of cohort studies. LANCET PUBLIC HEALTH, 8(9), E691-E700. Retrieved from https://www.webofscience.com/
Non-coding RNA-directed therapeutics in lung cancer: Delivery technologies and clinical applications
Abdellatif, A. A. H., Scagnetti, G., Younis, M. A., Bouazzaoui, A., Tawfeek, H. M., Aldosari, B. N., . . . Saleem, I. (2023). Non-coding RNA-directed therapeutics in lung cancer: Delivery technologies and clinical applications. COLLOIDS AND SURFACES B-BIOINTERFACES, 229. doi:10.1016/j.colsurfb.2023.113466
Candidate pathway analysis of surfactant proteins identifies CTSH and SFTA2 that influences lung cancer risk.
Luyapan, J., Bossé, Y., Li, Z., Xiao, X., Rosenberger, A., Hung, R. J., . . . Amos, C. I. (2023). Candidate pathway analysis of surfactant proteins identifies CTSH and SFTA2 that influences lung cancer risk.. Human molecular genetics, ddad095. doi:10.1093/hmg/ddad095
Plasma protein biomarkers for early prediction of lung cancer
Davies, M. P. A., Sato, T., Ashoor, H., Hou, L., Liloglou, T., Yang, R., & Field, J. K. (2023). Plasma protein biomarkers for early prediction of lung cancer. EBIOMEDICINE, 93. doi:10.1016/j.ebiom.2023.104686
Circulating Proteome for Pulmonary Nodule Malignancy.
Khodayari Moez, E., Warkentin, M. T., Brhane, Y., Lam, S., Field, J. K., Liu, G., . . . Hung, R. J. (2023). Circulating Proteome for Pulmonary Nodule Malignancy.. Journal of the National Cancer Institute, djad122. doi:10.1093/jnci/djad122
Mosaic chromosomal alterations is associated with increased lung cancer risk: insight from the INTEGRAL-ILCCO cohort analysis.
Cheng, C., Hong, W., Li, Y., Xiao, X., McKay, J., Han, Y., . . . INTEGRAL-ILCCO lung cancer consortium. (2023). Mosaic chromosomal alterations is associated with increased lung cancer risk: insight from the INTEGRAL-ILCCO cohort analysis.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, S1556-0864(23)00527-0. doi:10.1016/j.jtho.2023.05.001
Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program
Robbins, H. A., Alcala, K., Moez, E. K., Guida, F., Thomas, S., Zahed, H., . . . Hung, R. J. (2023). Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program. ANNALS OF EPIDEMIOLOGY, 77, 1-12. doi:10.1016/j.annepidem.2022.10.014
On the Non-Linearity of Radon-Induced Lung Cancer
2022
On the non-linearity of radon-induced lung cancer
On the non-linearity of radon-induced lung cancer
Circulating Proteome for Pulmonary Nodule Malignancy
EP01.06-006 Impact of Low Dose CT Screening on Cause of Death in Different Socio-Economic Groups
Davies, M. P. A., Vulkan, D., Gabe, R., Duffy, S. W., & Field, J. K. (2022). EP01.06-006 Impact of Low Dose CT Screening on Cause of Death in Different Socio-Economic Groups. Journal of Thoracic Oncology, 17(9), S190. doi:10.1016/j.jtho.2022.07.318
Genome-wide interaction analysis identified low-frequency variants with sex disparity in lung cancer risk
Li, Y., Xiao, X., Li, J., Byun, J., Cheng, C., Bosse, Y., . . . Amos, C. I. (2022). Genome-wide interaction analysis identified low-frequency variants with sex disparity in lung cancer risk. HUMAN MOLECULAR GENETICS, 31(16), 2831-2843. doi:10.1093/hmg/ddac030
On the non-linearity of radon-induced lung cancer
Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program
Impact of risk-based low dose CT screening on different socio-economic groups
Davies, M., Vulkan, D., Gabe, R., Duffy, S., & Field, J. (2022). Impact of risk-based low dose CT screening on different socio-economic groups. Lung Cancer, 165, S20. doi:10.1016/s0169-5002(22)00088-5
Gene-gene interaction of <i>AhR</i>with and within the <i>Wnt</i>cascade affects susceptibility to lung cancer
Rosenberger, A., Muttray, N., Hung, R. J., Christiani, D. C., Caporaso, N. E., Liu, G., . . . Bickeboeller, H. (2022). Gene-gene interaction of <i>AhR</i>with and within the <i>Wnt</i>cascade affects susceptibility to lung cancer. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 27(1). doi:10.1186/s40001-022-00638-7
Iam hiQ-a novel pair of accuracy indices for imputed genotypes
Rosenberger, A., Tozzi, V., Bickeboeller, H., & Consortium, I. N. T. E. G. R. A. L. -I. L. C. C. O. (2022). Iam hiQ-a novel pair of accuracy indices for imputed genotypes. BMC BIOINFORMATICS, 23(1). doi:10.1186/s12859-022-04568-3
Accounting for EGFR mutations in epidemiological analyses of non-small cell lung cancers: Examples based on the International Lung Cancer Consortium data.
Schmid, S., Jiang, M., Brown, M. C., Fares, A., Garcia, M., Soriano, J., . . . Liu, G. (2022). Accounting for EGFR mutations in epidemiological analyses of non-small cell lung cancers: Examples based on the International Lung Cancer Consortium data.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. doi:10.1158/1055-9965.epi-21-0747
Impact of Low Dose CT Screening on Cause of Death in Different Socio-Economic Groups
Davies, M. P. A., Vulkan, D., Gabe, R., Duffy, S. W., & Field, J. K. (2022). Impact of Low Dose CT Screening on Cause of Death in Different Socio-Economic Groups. In JOURNAL OF THORACIC ONCOLOGY Vol. 17 (pp. S190). Retrieved from https://www.webofscience.com/
2021
Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis
Field, J. K., Vulkan, D., Davies, M. P. A., Baldwin, D. R., Brain, K. E., Devaraj, A., . . . Duffy, S. W. (2021). Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis. LANCET REGIONAL HEALTH-EUROPE, 10. doi:10.1016/j.lanepe.2021.100179
OA19.02 The UKLS Trial Outcome Results: Lung Cancer Mortality Reduction by LDCT Screening Confirmed in an International Meta-Analysis
Field, J., Vulkan, D., Davies, M., Gabe, R., & Duffy, S. (2021). OA19.02 The UKLS Trial Outcome Results: Lung Cancer Mortality Reduction by LDCT Screening Confirmed in an International Meta-Analysis. Journal of Thoracic Oncology, 16(10), S882. doi:10.1016/j.jtho.2021.08.098
Gene-gene Interaction of AhR with and within the Wnt Cascade Affects Susceptibility to Lung Cancer
Genome-wide interaction analysis identified low-frequency variants with sex disparity in lung cancer risk
Gene-gene Interaction of AhR With and Within the Wnt Cascade Affects Susceptibility to Lung Cancer
Lung cancer risk in painters: results from the SYNERGY pooled case-control study consortium
Guha, N., Bouaoun, L., Kromhout, H., Vermeulen, R., Bruening, T., Behrens, T., . . . Olsson, A. (2021). Lung cancer risk in painters: results from the SYNERGY pooled case-control study consortium. OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 78(4), 269-278. doi:10.1136/oemed-2020-106770
FP07.02 Deep Learning Based Analysis of Multiplex IHC Accurately Interprets PD-L1 and Provides Prognostic Information in NSCLC
Haragan, A., Nekolla, K., Kapil, A., Brieu, N., Widmaier, M., Budco, A., . . . Gosney, J. (2021). FP07.02 Deep Learning Based Analysis of Multiplex IHC Accurately Interprets PD-L1 and Provides Prognostic Information in NSCLC. Journal of Thoracic Oncology, 16(3), S203. doi:10.1016/j.jtho.2021.01.102
FP09.02 Calibration of the LLP Lung Cancer Risk Stratification Model: Prospective Validation in the UKLS Cohort of 76,000 People
Field, J., Vulkan, D., Davies, M., Duffy, S., & Gabe, R. (2021). FP09.02 Calibration of the LLP Lung Cancer Risk Stratification Model: Prospective Validation in the UKLS Cohort of 76,000 People. Journal of Thoracic Oncology, 16(3), S212. doi:10.1016/j.jtho.2021.01.119
Rare deleterious germline variants and risk of lung cancer
Liu, Y., Xia, J., McKay, J., Tsavachidis, S., Xiao, X., Spitz, M. R., . . . Amos, C. I. (2021). Rare deleterious germline variants and risk of lung cancer. NPJ PRECISION ONCOLOGY, 5(1). doi:10.1038/s41698-021-00146-7
Liverpool Lung Project lung cancer risk stratification model: calibration and prospective validation
Field, J. K., Vulkan, D., Davies, M. P. A., Duffy, S. W., & Gabe, R. (2021). Liverpool Lung Project lung cancer risk stratification model: calibration and prospective validation. THORAX, 76(2), 161-168. doi:10.1136/thoraxjnl-2020-215158
The relationship between body-mass index and overall survival in non-small cell lung cancer by sex, smoking status, and race: A pooled analysis of 20,937 International lung Cancer consortium (ILCCO) patients
Jiang, M., Fares, A. F., Shepshelovich, D., Yang, P., Christiani, D., Zhang, J., . . . Liu, G. (2021). The relationship between body-mass index and overall survival in non-small cell lung cancer by sex, smoking status, and race: A pooled analysis of 20,937 International lung Cancer consortium (ILCCO) patients. Lung Cancer, 152, 58-65. doi:10.1016/j.lungcan.2020.11.029
2020
Protein-altering germline mutations implicate novel genes related to lung cancer development
Ji, X., Mukherjee, S., Landi, M. T., Bosse, Y., Joubert, P., Zhu, D., . . . Amos, C. I. (2020). Protein-altering germline mutations implicate novel genes related to lung cancer development. NATURE COMMUNICATIONS, 11. doi:10.1038/s41467-020-15905-6
Long non-coding RNA dysregulation is a frequent event in non-small cell lung carcinoma pathogenesis
Acha-Sagredo, A., Uko, B., Pantazi, P., Bediaga, N., Moschandrea, C., Rainbow, L., . . . Liloglou, T. (2020). Long non-coding RNA dysregulation is a frequent event in non-small cell lung carcinoma pathogenesis. British Journal of Cancer, 122(7), 1050-1058. doi:10.1038/s41416-020-0742-9
Immune-mediated genetic pathways resulting in pulmonary function impairment increase lung cancer susceptibility
Kachuri, L., Johansson, M., Rashkin, S. R., Graff, R. E., Bosse, Y., Manem, V., . . . Hung, R. J. (2020). Immune-mediated genetic pathways resulting in pulmonary function impairment increase lung cancer susceptibility. NATURE COMMUNICATIONS, 11(1). doi:10.1038/s41467-019-13855-2
2019
Potential genetic modifiers for somatic EGFR mutation in lung cancer: a meta-analysis and literature review
Cheng, Y. I., Gan, Y. C., Liu, D., Davies, M. P. A., Li, W. M., & Field, J. K. (2019). Potential genetic modifiers for somatic EGFR mutation in lung cancer: a meta-analysis and literature review. BMC CANCER, 19(1). doi:10.1186/s12885-019-6317-6
The Role of Autophagy in Lung Disease
Davies, M. P. A., & Wilson, C. M. (2016). The Role of Autophagy in Lung Disease. In AUTOPHAGY IN CURRENT TRENDS IN CELLULAR PHYSIOLOGY AND PATHOLOGY (pp. 267-285). doi:10.5772/64167
Implementation Planning of Lung Cancer Screening in China
Cheng, Y., Davies, M., Liu, D., Li, W., & Field, J. (2019). Implementation Planning of Lung Cancer Screening in China. In JOURNAL OF THORACIC ONCOLOGY Vol. 14 (pp. S1008). doi:10.1016/j.jtho.2019.08.2223
Pathogenic Germline Rare Variants and Risk of Lung Cancer
Liu, Y., Mckay, J., Xiao, X., Field, J., Davies, M., Brennan, P., . . . Amos, C. (2019). Pathogenic Germline Rare Variants and Risk of Lung Cancer. In JOURNAL OF THORACIC ONCOLOGY Vol. 14 (pp. S689-S690). doi:10.1016/j.jtho.2019.08.1465
Body Mass Index (BMI), BMI Change, and Overall Survival in Patients With SCLC and NSCLC: A Pooled Analysis of the International Lung Cancer Consortium
Shepshelovich, D., Xu, W., Lu, L., Fares, A., Yang, P., Christiani, D., . . . Hung, R. J. (2019). Body Mass Index (BMI), BMI Change, and Overall Survival in Patients With SCLC and NSCLC: A Pooled Analysis of the International Lung Cancer Consortium. JOURNAL OF THORACIC ONCOLOGY, 14(9), 1594-1607. doi:10.1016/j.jtho.2019.05.031
Heterogeneity of PD-L1 expression in non-small cell lung cancer: Implications for specimen sampling in predicting treatment response
Haragan, A., Field, J. K., Davies, M. P. A., Escriu, C., Gruver, A., & Gosney, J. R. (2019). Heterogeneity of PD-L1 expression in non-small cell lung cancer: Implications for specimen sampling in predicting treatment response. Lung Cancer, 134, 79-84. doi:10.1016/j.lungcan.2019.06.005
Lung Cancer Risk in Never-Smokers of European Descent is Associated With Genetic Variation in the 5<sub>p</sub>15.33 <i>TERT-CLPTM1Ll</i> Region
Hung, R. J., Spitz, M. R., Houlston, R. S., Schwartz, A. G., Field, J. K., Ying, J., . . . Gorlova, O. Y. (2019). Lung Cancer Risk in Never-Smokers of European Descent is Associated With Genetic Variation in the 5<sub>p</sub>15.33 <i>TERT-CLPTM1Ll</i> Region. JOURNAL OF THORACIC ONCOLOGY, 14(8), 1360-1369. doi:10.1016/j.jtho.2019.04.008
Investigation of Leukocyte Telomere Length and Genetic Variants in Chromosome 5p15.33 as Prognostic Markers in Lung Cancer
Kachuri, L., Helby, J., Bojesen, S. E., Christiani, D. C., Su, L., Wu, X., . . . Hung, R. J. (2019). Investigation of Leukocyte Telomere Length and Genetic Variants in Chromosome 5p15.33 as Prognostic Markers in Lung Cancer. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 28(7), 1228-1237. doi:10.1158/1055-9965.EPI-18-1215
Immune-mediated genetic pathways resulting in pulmonary function impairment increase lung cancer susceptibility
Kachuri, L., Johansson, M., Rashkin, S., Graff, R., Bossé, Y., Manem, V., . . . Hung, R. (2019). Immune-mediated genetic pathways resulting in pulmonary function impairment increase lung cancer susceptibility: bioRxiv. doi:10.1101/635318
Elevated Platelet Count Appears to Be Causally Associated with Increased Risk of Lung Cancer: A Mendelian Randomization Analysis
Zhu, Y., Wei, Y., Zhang, R., Dong, X., Shen, S., Zhao, Y., . . . Christiani, D. C. (2019). Elevated Platelet Count Appears to Be Causally Associated with Increased Risk of Lung Cancer: A Mendelian Randomization Analysis. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 28(5), 935-942. doi:10.1158/1055-9965.EPI-18-0356
PD-L1 Expression Heterogeneity in NSCLC: Accuracy and Reliability of Using Primary Lung Tumour Versus Metastatic Lymph Node Deposits
Haragan, A. K., Field, J. K., Davies, M. P. A., Escriu, C., Gruver, A., & Gosney, J. R. (2019). PD-L1 Expression Heterogeneity in NSCLC: Accuracy and Reliability of Using Primary Lung Tumour Versus Metastatic Lymph Node Deposits. In JOURNAL OF PATHOLOGY Vol. 248 (pp. S11). Retrieved from https://www.webofscience.com/
PD-L1 expression in resected non-small cell lung cancer: variation between primary tumour and nodal metastases
Haragan, A., Gosney, J., Field, J., Davies, M., Escriu, C., & Gruver, A. (2019). PD-L1 expression in resected non-small cell lung cancer: variation between primary tumour and nodal metastases. In Journal of Pathology Vol. 248 (pp. S11). Wiley-Blackwell.
Implementation planning for lung cancer screening in China
Cheng, Y. I., Davies, M. P. A., Liu, D., Li, W., & Field, J. K. (2019). Implementation planning for lung cancer screening in China. PRECISION CLINICAL MEDICINE, 2(1), 13-44. doi:10.1093/pcmedi/pbz002
Lung cancer screening programmes: landscape in China
Cheng, Y., Davies, M. P. A., Li, W., & Field, J. K. (2019). Lung cancer screening programmes: landscape in China. In LUNG CANCER Vol. 127 (pp. S60-S61). doi:10.1016/S0169-5002(19)30188-6
Systematic analyses of regulatory variants in DNase I hypersensitive sites identified two novel lung cancer susceptibility loci.
Dai, J., Li, Z., Amos, C. I., Hung, R. J., Tardon, A., Andrew, A., . . . Shen, H. (2019). Systematic analyses of regulatory variants in DNase I hypersensitive sites identified two novel lung cancer susceptibility loci.. Carcinogenesis. doi:10.1093/carcin/bgy187
PD-L1 expression in resected non-small cell lung cancer: variation between primary tumour and nodal metastases
Haragan, A., Gosney, J., Field, J. K., Davies, M., Escriu, C., & Gruver, A. (2019). PD-L1 expression in resected non-small cell lung cancer: variation between primary tumour and nodal metastases. In LUNG CANCER Vol. 127 (pp. S25). doi:10.1016/S0169-5002(19)30106-0
2018
Digital Core Needle-Biopsy to Assess PD-L1 Expression in Non-Small Cell Lung Cancer: Optimal Sampling and Need for Re-Biopsy
Haragan, A., Field, J., Davies, M., Escriu, C., Gruver, A., & Gosney, J. (2018). Digital Core Needle-Biopsy to Assess PD-L1 Expression in Non-Small Cell Lung Cancer: Optimal Sampling and Need for Re-Biopsy. In JOURNAL OF THORACIC ONCOLOGY Vol. 13 (pp. S534-S535). doi:10.1016/j.jtho.2018.08.739
Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung Cancer
Liu, Y., Lusk, C. M., Cho, M. H., Silverman, E. K., Qiao, D., Zhang, R., . . . Spitz, M. R. (2018). Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung Cancer. JOURNAL OF THORACIC ONCOLOGY, 13(10), 1483-1495. doi:10.1016/j.jtho.2018.06.016
Utilising Heterogeneity: Using a Digital Database of Lung Cancers and Immune Profile to Complement Subjective Assessment
Haragan, A., Field, J., Davies, M., Escriu, C., Gruver, A., & Gosney, J. (2018). Utilising Heterogeneity: Using a Digital Database of Lung Cancers and Immune Profile to Complement Subjective Assessment. In JOURNAL OF THORACIC ONCOLOGY Vol. 13 (pp. S768). doi:10.1016/j.jtho.2018.08.1316
Fine mapping of MHC region in lung cancer highlights independent susceptibility loci by ethnicity
Ferreiro-Iglesias, A., Lesseur, C., McKay, J., Hung, R. J., Han, Y., Zong, X., . . . Brennan, P. (2018). Fine mapping of MHC region in lung cancer highlights independent susceptibility loci by ethnicity. NATURE COMMUNICATIONS, 9, 12 pages. doi:10.1038/s41467-018-05890-2
2017
Common TDP1 Polymorphisms in Relation to Survival among Small Cell Lung Cancer Patients: A Multicenter Study from the International Lung Cancer Consortium
Lohavanichbutr, P., Sakoda, L. C., Amos, C. I., Arnold, S. M., Christiani, D. C., Davies, M. P. A., . . . Chen, C. (2017). Common TDP1 Polymorphisms in Relation to Survival among Small Cell Lung Cancer Patients: A Multicenter Study from the International Lung Cancer Consortium. CLINICAL CANCER RESEARCH, 23(24), 7550-7557. doi:10.1158/1078-0432.CCR-17-1401
Pleiotropy of genetic variants on obesity and smoking phenotypes: Results from the Oncoarray Project of The International Lung Cancer Consortium
Wang, T., Moon, J. -Y., Wu, Y., Amos, C. I., Hung, R. J., Tardon, A., . . . Ho, G. Y. F. (2017). Pleiotropy of genetic variants on obesity and smoking phenotypes: Results from the Oncoarray Project of The International Lung Cancer Consortium. PLOS ONE, 12(9). doi:10.1371/journal.pone.0185660
Common TDP1 polymorphisms in relation to survival among small cell lung cancer patients in a multicenter study from the International Lung Cancer Consortium
Lohavanichbutr, P., Sakoda, L. C., Amos, C. I., Arnold, S. M., Christiani, D. C., Davies, M. P., . . . Chen, C. (2017). Common <i>TDP1</i> polymorphisms in relation to survival among small cell lung cancer patients in a multicenter study from the International Lung Cancer Consortium. In CANCER RESEARCH Vol. 77. doi:10.1158/1538-7445.AM2017-2248
Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes
McKay, J. D., Hung, R. J., Han, Y., Zong, X., Carreras-Torres, R., Christiani, D. C., . . . Field, J. K. (2017). Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes.. Nature Genetics, 49(7), 1126-1132. doi:10.1038/ng.3892
AURKA mRNA expression is an independent predictor of poor prognosis in patients with non-small cell lung cancer
Al-Khafaji, A. S. K., Marcus, M. W., Davies, M. P. A., Risk, J. M., Shaw, R. J., Field, J. K., & Liloglou, T. (2017). AURKA mRNA expression is an independent predictor of poor prognosis in patients with non-small cell lung cancer. Oncology letters, 13(6), 4463-4468. doi:10.3892/ol.2017.6012
Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study
Carreras-Torres, R., Johansson, M., Haycock, P. C., Wade, K. H., Relton, C. L., Martin, R. M., . . . Brennan, P. (2017). Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study. PLOS ONE, 12(6). doi:10.1371/journal.pone.0177875
Aurora B expression modulates paclitaxel response in non-small cell lung cancer.
Al-Khafaji, A. S., Davies, M. P., Risk, J. M., Marcus, M. W., Koffa, M., Gosney, J. R., . . . Liloglou, T. (2017). Aurora B expression modulates paclitaxel response in non-small cell lung cancer.. British journal of cancer, 116(05), 592-599. doi:10.1038/bjc.2016.453
The Non-Invasive LuCED® Test for Detection of Early Stage Lung Cancer
Meyer, M., Bell, T., Sussman, D., Wilbur, D., Presley, C., Hayenga, J., . . . Nelson, A. (2017). The Non-Invasive LuCED® Test for Detection of Early Stage Lung Cancer. In JOURNAL OF THORACIC ONCOLOGY Vol. 12 (pp. S343-S344). doi:10.1016/j.jtho.2016.11.375
2016
The causal relevance of body mass index in different histological types of lung cancer: A Mendelian randomization study
Carreras-Torres, R., Haycock, P. C., Relton, C. L., Martin, R. M., Smith, G. D., Kraft, P., . . . Brennan, P. (2016). The causal relevance of body mass index in different histological types of lung cancer: A Mendelian randomization study. SCIENTIFIC REPORTS, 6. doi:10.1038/srep31121
Silicon Nanowire Sensors Enable Diagnosis of Patients <i>via</i> Exhaled Breath
Shehada, N., Cancilla, J. C., Torrecilla, J. S., Pariente, E. S., Broenstrup, G., Christiansen, S., . . . Haick, H. (2016). Silicon Nanowire Sensors Enable Diagnosis of Patients <i>via</i> Exhaled Breath. ACS NANO, 10(7), 7047-7057. doi:10.1021/acsnano.6b03127
Fine mapping of chromosome 5p15.33 based on a targeted deep sequencing and high density genotyping identifies novel lung cancer susceptibility loci
Kachuri, L., Amos, C. I., Mckay, J. D., Johansson, M., Vineis, P., Bueno-de-Mesquita, H. B., . . . Hung, R. J. (2016). Fine mapping of chromosome 5p15.33 based on a targeted deep sequencing and high density genotyping identifies novel lung cancer susceptibility loci. CARCINOGENESIS, 37(1), 96-105. doi:10.1093/carcin/bgv165
2015
Differentiation between genetic mutations of breast cancer by breath volatolomics
Barash, O., Zhang, W., Halpern, J. M., Hua, Q. -L., Pan, Y. -Y., Kayal, H., . . . Haick, H. (2015). Differentiation between genetic mutations of breast cancer by breath volatolomics. ONCOTARGET, 6(42), 44864-44876. doi:10.18632/oncotarget.6269
Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer Consortium
Huang, R., Wei, Y., Hung, R. J., Liu, G., Su, L., Zhang, R., . . . Christiani, D. C. (2015). Associated Links Among Smoking, Chronic Obstructive Pulmonary Disease, and Small Cell Lung Cancer: A Pooled Analysis in the International Lung Cancer Consortium. EBIOMEDICINE, 2(11), 1677-1685. doi:10.1016/j.ebiom.2015.09.031
Identification of lung cancer histology-specific variants applying Bayesian framework variant prioritization approaches within the TRICL and ILCCO consortia
Brenner, D. R., Amos, C. I., Brhane, Y., Timofeeva, M. N., Caporaso, N., Wang, Y., . . . Hung, R. J. (2015). Identification of lung cancer histology-specific variants applying Bayesian framework variant prioritization approaches within the TRICL and ILCCO consortia. Carcinogenesis, 36(11), 1314-1326. doi:10.1093/carcin/bgv128
Lung cancer trend in England for the period of 2002 to 2011 and projections of future burden until 2020
Olajide, O. O., Field, J. K., Davies, M. M. P. A., & Marcus, M. W. (2015). Lung cancer trend in England for the period of 2002 to 2011 and projections of future burden until 2020. INTERNATIONAL JOURNAL OF ONCOLOGY, 47(2), 739-746. doi:10.3892/ijo.2015.3049
Lung cancer trend in England for the period of 2002 to 2011 and projections of future burden until 2020
OLAJIDE, O. O., FIELD, J. K., DAVIES, M. M. P. A., & MARCUS, M. W. (2015). Lung cancer trend in England for the period of 2002 to 2011 and projections of future burden until 2020. International Journal of Oncology, 47(2), 739-746. doi:10.3892/ijo.2015.3049
Application of SureSeq solid tumour panel sequencing to a panel of FFPE samples of non small cell lung cancer from the Liverpool lung project
Hyde, R., Davies, M. P. A., Gosney, J., & Field, J. (2015). Application of SureSeq solid tumour panel sequencing to a panel of FFPE samples of non small cell lung cancer from the Liverpool lung project. In LUNG CANCER Vol. 87 (pp. S5). doi:10.1016/S0169-5002(15)50011-1
Volatile biomarkers for discrimination of lung cancer risk and mutation
Davies, M. P. A., Barash, O., Jeries, R., Peled, N., Ilouze, M., Hyde, R., . . . Field, J. (2015). Volatile biomarkers for discrimination of lung cancer risk and mutation. In LUNG CANCER Vol. 87 (pp. S4-S5). doi:10.1016/S0169-5002(15)50010-X
2014
Unique volatolomic signatures of TP53 and KRAS in lung cells
Davies, M. P. A., Barash, O., Jeries, R., Peled, N., Ilouze, M., Hyde, R., . . . Haick, H. (2014). Unique volatolomic signatures of TP53 and KRAS in lung cells. BRITISH JOURNAL OF CANCER, 111(6), 1213-1221. doi:10.1038/bjc.2014.411
Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids
Fernandez-Cuesta, L., Peifer, M., Lu, X., Sun, R., Ozretic, L., Seidel, D., . . . Thomas, R. K. (2014). Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids. NATURE COMMUNICATIONS, 5. doi:10.1038/ncomms4518
Epigenetic biomarkers in lung cancer
Liloglou, T., Bediaga, N. G., Brown, B. R. B., Field, J. K., & Davies, M. P. A. (2014). Epigenetic biomarkers in lung cancer. CANCER LETTERS, 342(2), 200-212. doi:10.1016/j.canlet.2012.04.018
2013
A Prognostic DNA Methylation Signature for Stage I Non-Small-Cell Lung Cancer
Sandoval, J., Mendez-Gonzalez, J., Nadal, E., Chen, G., Carmona, F. J., Sayols, S., . . . Esteller, M. (2013). A Prognostic DNA Methylation Signature for Stage I Non-Small-Cell Lung Cancer. JOURNAL OF CLINICAL ONCOLOGY, 31(32), 4140-+. doi:10.1200/JCO.2012.48.5516
A microRNA-based prediction algorithm for diagnosis of non-small lung cell carcinoma in minimal biopsy material
Bediaga, N. G., Davies, M. P. A., Acha-Sagredo, A., Hyde, R., Raji, O. Y., Page, R., . . . Liloglou, T. (2013). A microRNA-based prediction algorithm for diagnosis of non-small lung cell carcinoma in minimal biopsy material. BRITISH JOURNAL OF CANCER, 109(9), 2404-2411. doi:10.1038/bjc.2013.623
2012
PRE-clinical investigation of AT7519, a novel CDK inhibitor, as a potential therapeutic agent in pancreatic cancer
Thomas, A., Shaw, E., Ghaneh, P., Greenhalf, W., Davies, M., Costello, E., . . . Neoptolemos, J. P. (2012). PRE-clinical investigation of AT7519, a novel CDK inhibitor, as a potential therapeutic agent in pancreatic cancer. Pancreatology, 12(3), e10. doi:10.1016/j.pan.2012.03.023
Pre-clinical assessment of AT13387, an HSP90 inhibitor, in a pancreatic cancer xenograft model
Shaw, E., Thomas, A., Ghaneh, P., Greenhalf, W., Davies, M., Costello, E., . . . Sibson, D. R. (2012). Pre-clinical assessment of AT13387, an HSP90 inhibitor, in a pancreatic cancer xenograft model. Pancreatology, 12(3), e7-e8. doi:10.1016/j.pan.2012.03.020
MicroRNAs for early detection of lung cancer
Bediaga, N., Davies, M. P. A., Raji, O. Y., Alfirevic, A., Liloglou, T., & Field, J. K. (2012). MicroRNAs for early detection of lung cancer. CANCER RESEARCH, 72. doi:10.1158/1538-7445.AM2012-4133
2010
Expression of the rat calcium-binding protein p9Ka in transgenic mice.
Davies, M. P. A. (2010). Expression of the rat calcium-binding protein p9Ka in transgenic mice..
Microarray analysis of suppression subtracted hybridisation libraries identifies genes associated with breast cancer progression
Barraclough, D. L., Sewart, S., Rudland, P. S., Shoker, B. S., Sibson, D. R., Barraclough, R., & Davies, M. P. A. (2010). Microarray analysis of suppression subtracted hybridisation libraries identifies genes associated with breast cancer progression. CELLULAR ONCOLOGY, 32(1-2), 87-99. doi:10.3233/CLO-2009-0499
Microarray Analysis of Suppression Subtracted Hybridisation Libraries Identifies Genes Associated with Breast Cancer Progression
Barraclough, D. L., Sewart, S., Rudland, P. S., Shoker, B. S., Sibson, D. R., Barraclough, R., & Davies, M. P. A. (2010). Microarray Analysis of Suppression Subtracted Hybridisation Libraries Identifies Genes Associated with Breast Cancer Progression. Analytical Cellular Pathology, 32(1-2), 87-99. doi:10.1155/2010/582416
2008
Expression and splicing of the unfolded protein response gene XBP-1 are sieniticantly associated with clinical outcome of endocrine-treated breast cancer
Davies, M. P. A., Barraclough, D. L., Stewart, C., Joyce, K. A., Eccles, R. M., Barraclough, R., . . . Sibson, D. R. (2008). Expression and splicing of the unfolded protein response gene XBP-1 are sieniticantly associated with clinical outcome of endocrine-treated breast cancer. INTERNATIONAL JOURNAL OF CANCER, 123(1), 85-88. doi:10.1002/ijc.23479
2007
Association of oestrogen receptor beta 2 (ERβ2/ERβcx) with outcome of adjuvant endocrine treatment for primary breast cancer -: a retrospective study
Vinayagam, R., Sibson, D. R., Holcombe, C., Aachi, V., & Davies, M. P. (2007). Association of oestrogen receptor beta 2 (ERβ2/ERβcx) with outcome of adjuvant endocrine treatment for primary breast cancer -: a retrospective study. BMC CANCER, 7. doi:10.1186/1471-2407-7-131
2006
Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients
Innes, H. E., Liu, D., Barraclough, R., Davies, M. P. A., O'Neill, P. A., Platt-Higgins, A., . . . Rudland, P. S. (2006). Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients. BRITISH JOURNAL OF CANCER, 94(7), 1057-1065. doi:10.1038/sj.bjc.6603065
2005
Hypersensitive K303R oestrogen receptor-α variant not found in invasive carcinomas
Davies, M. P. A., O'Neill, P. A., Innes, H., & Sibson, D. R. (2005). Hypersensitive K303R oestrogen receptor-α variant not found in invasive carcinomas. BREAST CANCER RESEARCH, 7(1), R113-R118. doi:10.1186/bcr965
2004
Correlation of mRNA for oestrogen receptor beta splice variants ERβ1, ERβ2/ERβcx and ERβ5 with outcome in endocrine-treated breast cancer
Davies, M. P. A., O'Neill, P. A., Innes, H., Sibson, D. R., Prime, W., Holcombe, C., & Foster, C. S. (2004). Correlation of mRNA for oestrogen receptor beta splice variants ERβ1, ERβ2/ERβcx and ERβ5 with outcome in endocrine-treated breast cancer. JOURNAL OF MOLECULAR ENDOCRINOLOGY, 33(3), 773-782. doi:10.1677/jme.1.01574
Wild-type oestrogen receptor beta (ERb1) mRNA and protein expression in Tamoxifen-treated post-menopausal breast cancers
O'Neill, P. A., Davies, M. P. A., Shaaban, A. M., Innes, H., Torevell, A., Sibson, D. R., & Foster, C. S. (2004). Wild-type oestrogen receptor beta (ERb1) mRNA and protein expression in Tamoxifen-treated post-menopausal breast cancers. BRITISH JOURNAL OF CANCER, 91(9), 1694-1702. doi:10.1038/sj.bjc.6602183
Increased risk of malignant progression in benign proliferating breast lesions defined by expression of heat shock protein 27
O'Neill, P. A., Shaaban, A. M., West, C. R., Dodson, A., Jarvis, C., Moore, P., . . . Foster, C. S. (2004). Increased risk of malignant progression in benign proliferating breast lesions defined by expression of heat shock protein 27. BRITISH JOURNAL OF CANCER, 90(1), 182-188. doi:10.1038/sj.bjc.6601449
2003
Declining estrogen receptor-β expression defines malignant progression of human breast neoplasia
Shaaban, A. M., O'Neill, P. A., Davies, M. P. A., Sibson, R., West, C. R., Smith, P. H., & Foster, C. S. (2003). Declining estrogen receptor-β expression defines malignant progression of human breast neoplasia. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 27(12), 1502-1512. doi:10.1097/00000478-200312000-00002
Examination of tumour histopathology and gene expression in a <i>neu</i>/<i>S100A4</i> transgenic model of metastatic breast cancer
Simpson, P. T., Shoker, B. S., Barraclough, R., Halliwell, N., Rudland, P. S., Sibson, D. R., & Davies, M. P. A. (2003). Examination of tumour histopathology and gene expression in a <i>neu</i>/<i>S100A4</i> transgenic model of metastatic breast cancer. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 84(4), 173-183. doi:10.1046/j.1365-2613.2003.00350.x
2002
Molecular and genetic abnormalities in radial scar
Iqbal, M., Shoker, B. S., Foster, C. S., Jarvis, C., Sibson, D. R., & Davies, M. P. A. (2002). Molecular and genetic abnormalities in radial scar. HUMAN PATHOLOGY, 33(7), 715-722. doi:10.1053/hupa.2002.125375
2001
Hypersensitive K303R oestrogen receptor variant not found in ductal carcinoma in situ
Davies, M. P. A., Iqbal, M., Shoker, B. S., & Sibson, D. R. (2001). Hypersensitive K303R oestrogen receptor variant not found in ductal carcinoma in situ. European Journal of Cancer, 37, 29. doi:10.1016/s0959-8049(01)80116-7
Immunodetectable cyclin D<sub>1</sub> is associated with oestrogen receptor but not Ki67 in normal, cancerous and precancerous breast lesions
Shoker, B. S., Jarvis, C., Davies, M. P. A., Iqbal, M., Sibson, D. R., & Sloane, J. P. (2001). Immunodetectable cyclin D<sub>1</sub> is associated with oestrogen receptor but not Ki67 in normal, cancerous and precancerous breast lesions. BRITISH JOURNAL OF CANCER, 84(8), 1064-1069. doi:10.1054/bjoc.2001.1705
Characterisation of molecular alterations in microdissected archival gliomas
Walker, C., Joyce, K. A., Thompson-Hehir, J., Davies, M. P. A., Gibbs, F. E. M., Halliwell, N., . . . Rossi, M. L. (2001). Characterisation of molecular alterations in microdissected archival gliomas. ACTA NEUROPATHOLOGICA, 101(4), 321-333. Retrieved from https://www.webofscience.com/
Subgroups of non-atypical hyperplasia of breast defined by proliferation of oestrogen receptor-positive cells
Iqbal, M., Davies, M. P. A., Shoker, B. S., Jarvis, C., Sibson, D. R., & Sloane, J. P. (2001). Subgroups of non-atypical hyperplasia of breast defined by proliferation of oestrogen receptor-positive cells. JOURNAL OF PATHOLOGY, 193(3), 333-338. doi:3.0.CO;2-#">10.1002/1096-9896(2000)9999:9999<::AID-PATH801>3.0.CO;2-#
2000
Abnormal regulation of the oestrogen receptor in benign breast lesions
Shoker, B. S., Jarvis, C., Clarke, R. B., Anderson, E., Munro, C., Davies, M. P. A., . . . Sloane, J. P. (2000). Abnormal regulation of the oestrogen receptor in benign breast lesions. JOURNAL OF CLINICAL PATHOLOGY, 53(10), 778-783. doi:10.1136/jcp.53.10.778
Novel polymerase chain reaction approach for full-coding p53 mutation detection in microdissected archival tumors
Thompson-Hehir, J., Davies, M. P. A., Green, J. A., Halliwell, N., Joyce, K. A., Salisbury, J., . . . Walker, C. (2000). Novel polymerase chain reaction approach for full-coding p53 mutation detection in microdissected archival tumors. DIAGNOSTIC MOLECULAR PATHOLOGY, 9(2), 110-119. doi:10.1097/00019606-200006000-00007
1999
Estrogen receptor-positive proliferating cells in the normal and precancerous breast
Shoker, B. S., Jarvis, C., Clarke, R. B., Anderson, E., Hewlett, J., Davies, M. P. A., . . . Sloane, J. P. (1999). Estrogen receptor-positive proliferating cells in the normal and precancerous breast. AMERICAN JOURNAL OF PATHOLOGY, 155(6), 1811-1815. doi:10.1016/S0002-9440(10)65498-3
Mutation in the <i>PTEN/MMAC1</i> gene in archival low grade and high grade gliomas
Davies, M. P. A., Gibbs, F. E. M., Halliwell, N., Joyce, K. A., Roebuck, M. M., Rossi, M. L., . . . Walker, C. (1999). Mutation in the <i>PTEN/MMAC1</i> gene in archival low grade and high grade gliomas. BRITISH JOURNAL OF CANCER, 79(9-10), 1542-1548. doi:10.1038/sj.bjc.6690246
1998
Use of DNA transfer in the induction of metastasis in experimental mammary systems
Barraclough, R., Chen, H. J., Davies, B. R., Davies, M. P. A., Ke, Y. Q., Lloyd, B. H., . . . Rudland, P. S. (1998). Use of DNA transfer in the induction of metastasis in experimental mammary systems. MAMMARY DEVELOPMENT IN CANCER, (63), 273-294. Retrieved from https://www.webofscience.com/
1997
Transcriptional down-regulation of the metastasis-inducing S100A4 (p9Ka) in benign but not in malignant rat mammary epithelial cells by GC-factor
Chen, D. S., Davies, M. P. A., Rudland, P. S., & Barraclough, R. (1997). Transcriptional down-regulation of the metastasis-inducing S100A4 (p9Ka) in benign but not in malignant rat mammary epithelial cells by GC-factor. JOURNAL OF BIOLOGICAL CHEMISTRY, 272(32), 20283-20290. doi:10.1074/jbc.272.32.20283
Elevated expression of calcium-binding protein p9Ka is associated with increasing malignant characteristics of rat prostate carcinoma cells
Ke, Y. Q., Jing, C., Barraclough, R., Smith, P., Davies, M. P. A., & Foster, C. S. (1997). Elevated expression of calcium-binding protein p9Ka is associated with increasing malignant characteristics of rat prostate carcinoma cells. INTERNATIONAL JOURNAL OF CANCER, 71(5), 832-837. doi:3.0.CO;2-8">10.1002/(SICI)1097-0215(19970529)71:5<832::AID-IJC22>3.0.CO;2-8
1996
Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours
Davies, M. P. A., Rudland, P. S., Robertson, L., Parry, E. W., Jolicoeur, P., & Barraclough, R. (1996). Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours. ONCOGENE, 13(8), 1631-1637. Retrieved from https://www.webofscience.com/
Growth & mammary abnormalities in mice containing an altered calcium-binding protein transgene
Davies, M. P. A., Harris, S., Rudland, P. S., & Barraclough, R. (1996). Growth & mammary abnormalities in mice containing an altered calcium-binding protein transgene. BIOCHEMICAL SOCIETY TRANSACTIONS, 24(3), S356. doi:10.1042/bst024356s
1995
EXPRESSION OF THE RAT, S-100-RELATED, CALCIUM-BINDING PROTEIN GENE, P9KA, IN TRANSGENIC MICE DEMONSTRATES DIFFERENT PATTERNS OF EXPRESSION BETWEEN THESE 2 SPECIES
DAVIES, M., HARRIS, S., RUDLAND, P., & BARRACLOUGH, R. (1995). EXPRESSION OF THE RAT, S-100-RELATED, CALCIUM-BINDING PROTEIN GENE, P9KA, IN TRANSGENIC MICE DEMONSTRATES DIFFERENT PATTERNS OF EXPRESSION BETWEEN THESE 2 SPECIES. DNA AND CELL BIOLOGY, 14(10), 825-832. doi:10.1089/dna.1995.14.825
1993
Induction of the metastatic phenotype in rat mammary benign tumour cells by the gene for p9Ka a novel calcium-binding protein
Barraclough, R., Davies, B. R., Davies, M. P. A., Gibbs, F. E. M., & Rudland, P. S. (1993). Induction of the metastatic phenotype in rat mammary benign tumour cells by the gene for p9Ka a novel calcium-binding protein. The Breast, 2(3), 191. doi:10.1016/0960-9776(93)90090-3
INDUCTION OF THE METASTATIC PHENOTYPE BY TRANSFECTION OF A BENIGN RAT MAMMARY EPITHELIAL-CELL LINE WITH THE GENE FOR P9KA, A RAT CALCIUM-BINDING PROTEIN, BUT NOT WITH THE ONCOGENE EJ-RAS-1
DAVIES, B. R., DAVIES, M. P. A., GIBBS, F. E. M., BARRACLOUGH, R., & RUDLAND, P. S. (1993). INDUCTION OF THE METASTATIC PHENOTYPE BY TRANSFECTION OF A BENIGN RAT MAMMARY EPITHELIAL-CELL LINE WITH THE GENE FOR P9KA, A RAT CALCIUM-BINDING PROTEIN, BUT NOT WITH THE ONCOGENE EJ-RAS-1. ONCOGENE, 8(4), 999-1008. Retrieved from https://www.webofscience.com/
PRODUCTION OF THE METASTATIC PHENOTYPE BY DNA TRANSFECTION IN A RAT MAMMARY MODEL
DAVIES, B. R., BARRACLOUGH, R., DAVIES, M. P. A., & RUDLAND, P. S. (1993). PRODUCTION OF THE METASTATIC PHENOTYPE BY DNA TRANSFECTION IN A RAT MAMMARY MODEL. CELL BIOLOGY INTERNATIONAL, 17(9), 871-879. doi:10.1006/cbir.1993.1150
1990
USE OF FLUO-3 TO MEASURE CYTOSOLIC CA-2+ IN PLATELETS AND NEUTROPHILS - LOADING CELLS WITH THE DYE, CALIBRATION OF TRACES, MEASUREMENTS IN THE PRESENCE OF PLASMA, AND BUFFERING OF CYTOSOLIC CA-2+
MERRITT, J. E., MCCARTHY, S. A., DAVIES, M. P. A., & MOORES, K. E. (1990). USE OF FLUO-3 TO MEASURE CYTOSOLIC CA-2+ IN PLATELETS AND NEUTROPHILS - LOADING CELLS WITH THE DYE, CALIBRATION OF TRACES, MEASUREMENTS IN THE PRESENCE OF PLASMA, AND BUFFERING OF CYTOSOLIC CA-2+. BIOCHEMICAL JOURNAL, 269(2), 513-519. doi:10.1042/bj2690513
A ROLE FOR CALCIUM AND PROTEIN KINASE-C IN AGONIST-STIMULATED ADHESION OF HUMAN NEUTROPHILS
DAVIES, M. P. A., HALLAM, T. J., & MERRITT, J. E. (1990). A ROLE FOR CALCIUM AND PROTEIN KINASE-C IN AGONIST-STIMULATED ADHESION OF HUMAN NEUTROPHILS. BIOCHEMICAL JOURNAL, 267(1), 13-16. doi:10.1042/bj2670013
1989
A ROLE FOR CYTOPLASMIC CALCIUM IN THE STIMULATION OF NEUTROPHIL ADHESION
DAVIES, M. P. A., MOORES, K. E., & MERRITT, J. E. (1989). A ROLE FOR CYTOPLASMIC CALCIUM IN THE STIMULATION OF NEUTROPHIL ADHESION. BIOCHEMICAL SOCIETY TRANSACTIONS, 17(1), 123. doi:10.1042/bst0170123